Mayer Brown

Mayer Brown is recommended nationally for general patent litigation and Hatch-Waxman disputes for branded drug makers. In addition to the firm's contentious practice, the firm is also notable for its work in patent strategy, exemplified by its activity as IP counsel on complex life sciences deals.

IP practice group co-chair Lisa Ferri is a standout practitioner at the firm, and was shortlisted for the New York Patent Litigator of the year award by LMG Life Sciences. Her matters from the past year include representing Sanofi against the Washington Research Foundation in a suit related to the client’s drug Elitek, and a case for Gilead against eleven generic challengers seeking to market versions of branded Lexiscan. Ferri was also active as patent counsel on several M&A and licensing matters.

New York-based Brian Nolan is well versed in patent litigation, counseling and due diligence. He was recently active for Alexion as IP counsel in its $1.4 billion acquisition of Portola Pharmaceuticals. In litigation, he is lead counsel for the same client in a patent dispute opposite Chugai. Joseph Mahoney contributes to the firm's strength in Hatch-Waxman and Patent Office disputes. His life sciences expertise is bolstered by a Doctor of Pharmacy degree.

Patent attorney Vera Nackovic specializes in strategic counseling for clients in the pharmaceutical, biologics and medical device areas, among others.

Headquartered in Chicago with an additional 25 offices worldwide, Mayer Brown is an international, full-service law firm with a significant presence in the life sciences space. In particular, the firm is noted for its robust antitrust and product liability practices.

In Washington, DC, Andrew Tauber contributes significant expertise in the product liability area, and was one of the few Attorney of the Year Award finalists in the area for 2020. Tauber’s practice drew attention for his involvement in one of the Non-IP Litigation Impact Cases of the Year, Delfino v Medtronic. He and a Mayer Brown team including Daniel Ring acted for Medtronic before the Minnesota Court of Appeals in this noteworthy product liability case dealing with preemption following the landmark Merck v Albrecht ruling. Tauber is a member of the firm’s appellate and Supreme Court practice, and Ring is co-chair of the product liability and mass torts group.

New York partner Hank Bullock supports the firm’s strong offering in product liability, recently acting for GlaxoSmithKline in more than 10 actions stemming from claims brought against the client’s Lamictal product. The firm is active as counsel for the discovery, trial and appellate stages of the case.